Rhumbline Advisers Third Harmonic Bio, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 28,171 shares of THRD stock, worth $145,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,171
Previous 28,922
2.6%
Holding current value
$145,080
Previous $297,000
67.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding THRD
# of Institutions
96Shares Held
38MCall Options Held
76.6KPut Options Held
22.8K-
Atlas Venture Life Science Advisors, LLC10.4MShares$53.6 Million10.57% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$29.8 Million0.63% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.82MShares$19.7 Million10.74% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.94MShares$15.1 Million0.46% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.51MShares$12.9 Million2.09% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $208M